Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction

Redox Biology

Volumn 2, Issue 1, 2013, Pages 1-7

  Qipshidze Kelm, Natia ^a   Piell, Kellianne M ^a   Solinger, Jane C ^a   Cole, Marsha P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Apoptosis; Conjugated linoleic acid; Drp 1; Myocardial infarction; Nitrite

Indexed keywords

CONJUGATED LINOLEIC ACID; DRINKING WATER; DYNAMIN; DYNAMIN RELATED PROTEIN 1; HEME OXYGENASE 1; MICRORNA; MICRORNA 499; NITRITE; PROTEIN P53; UNCLASSIFIED DRUG; PRE MICRORNA 499; DNM1L PROTEIN, MOUSE; MIRN499 MICRORNA, MOUSE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENZYME REGULATION; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART INFARCTION; HEART PROTECTION; HEART WEIGHT; HEMODYNAMICS; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; UPREGULATION; CORONARY ARTERY LIGATION; ANIMAL; C57BL MOUSE; HEART; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY;

MUS;

ANIMALS; DYNAMINS; ECHOCARDIOGRAPHY; HEART; HEME OXYGENASE-1; HEMODYNAMICS; LINOLEIC ACIDS, CONJUGATED; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIAL INFARCTION; NITRITES; PROTECTIVE AGENTS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84888397022     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.10.009     Document Type: Article

References (49)

1. Klocke R., Tian W., Kuhlmann M.T., Nikol S. Surgical animal models of heart failure related to coronary heart disease. Cardiovasc. Res. 2007, 74:29-38.
2. Hori M., Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009, 81:457-464.
3. Landmesser U., Wollert K.C., Drexler H. Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc. Res. 2009, 81:519-527.
4. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc. Res. 2009, 81:482-490.
5. Choong-Chin L., Victor J.D. Molecular genetics and genomics of heart failure. Nat. Rev. Genet. 2004, 5:811-825.
6. Lowes B.D., Gilbert E.M., Abraham W.T., Minobe W.A., Larrabee P., Ferguson D., Wolfel E.E., Lindenfeld J., Tsvetkova T., Robertson A.D., Quaife R.A., Bristow M.R. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 2002, 346:1357-1365.
7. Kaab S., Barth A., Margerie D., Dugas M., Gebauer M., Zwermann L., Merk S., Pfeufer A., Steinmeyer K., Bleich M., Kreuzer E., Steinbeck G., Näbauer M. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J. Mol. Med. 2004, 82:308-316.
8. Barth A.S., Kuner R., Buness A., Ruschhaupt M., Merk S., Zwermann L., Kääb S., Kreuzer E., Steinbeck G., Mansmann U., Poustka A., Nabauer M., Sültmann H. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J. Am. Coll. Cardiol. 2006, 48:1610-1617.
9. Movassagh M., Choy M.-K., Goddard M., Bennett M.R., Down T.A., Foo R.S.Y. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010, 5:e8564.
10. Izumo S., Nadal-Ginard B., Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Nat. Acad. Sci. 1988, 85:339-343.
11. van Empel V.P.M., Bertrand A.T.A., Hofstra L., Crijns H.J., Doevendans P.A., De Windt L.J. Myocyte apoptosis in heart failure. Cardiovasc. Res. 2005, 67:21-29.
12. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., Shirani J., Armstrong R.C., Kitsis R.N. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 2003, 111:1497-1504.
13. Jordan S.F., Scott W.L. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
14. Long X., Boluyt M.O., Hipolito M.L., Lundberg M.S., Zheng J.S., O'Neill L., Cirielli C., Lakatta E.G., Crow M.T. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest. 1997, 99:2635-2643.
15. Crow M.T., Mani K., Nam Y.-J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 2004, 95:957-970.
16. Shieh J.T.C., Huang Y., Gilmore J., Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011, 6.
17. Zhu H., Fan G.-C. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res. 2012, 94:284-292.
18. Wang J.X., Jiao J.Q., Li Q., Long B., Wang K., Liu J.P., Li Y.R., Li P.F. miR-499 Regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 2011, 17:71-78.
19. Adachi T., Nakanishi M., Otsuka Y., Nishimura K., Hirokawa G., Goto Y., Nonogi H., Iwai N. Plasma MicroRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem. 2010, 56:1183-1185.
20. Stampfer M.J., Hu F.B., Manson J.E., Rimm E.B., Willett W.C. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 2000, 343:16-22.
21. Gebauer S.K., Chardigny J.-M., Jakobsen M.U., Lamarche B., Lock A.L., Proctor S.D., Baer D.J. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv. Nutr.: Int. Rev. J. 2011, 2:332-354.
22. van de Vossenberg J.L.C.M, Joblin K.N. Biohydrogenation of C18 unsaturated fatty acids to stearic acid by a strain of Butyrivibrio hungatei from the bovine rumen. Lett. Appl. Microbiol. 2003, 37:424-428.
23. Campbell W., Drake M.A., Larick D.K. The impact of fortification with conjugated linoleic acid (CLA) on the quality of fluid milk. J. Dairy Sci. 2003, 86:43-51.
24. Pariza M.W., Park Y., Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res. 2001, 40:283-298.
25. Freeman B.A., Baker P.R.S., Schopfer F.J., Woodcock S.R., Napolitano A., d'Ischia M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 2008, 283:15515-15519.
26. Bonacci G., Baker P.R.S., Salvatore S.R., Shores D., Khoo N.K.H., Koenitzer J.R., Vitturi D.A., Woodcock S.R., Golin-Bisello F., Cole M.P., Watkins S., St.Croix C., Batthyany C.I., Freeman B.A., Schopfer F.J. Conjugated linoleic acid is a preferential substrate for fatty acid nitration. J. Biol. Chem. 2012, 287:44071-44082.
27. Ryter S.W., Alam J., Choi A.M.K. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006, 86:583-650.
28. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997, 37:517-554.
29. Paine A., Eiz-Vesper B., Blasczyk R., Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 2010, 80:1895-1903.
30. Wang G., Hamid T., Keith R.J., Zhou G., Partridge C.R., Xiang X., Kingery J.R., Lewis R.K., Li Q., Rokosh D.G., Ford R., Spinale F.G., Riggs D.W., Srivastava S., Bhatnagar A., Bolli R., Prabhu S.D. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010, 121:1912-1925.
31. Ong S.-B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121.
32. Dimmer K.S., Scorrano L. (De)constructing mitochondria: what for?. Physiology 2006, 21:233-241.
33. Hausenloy D.J., Scorrano L. Targeting cell death. Clin. Pharmacol. Ther. 2007, 82:370-373.
34. Chen H., Chan D.C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Gen. 2009, 18.
35. Suen D.-F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008, 22.
36. Liesa M., Palacín M., Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol. Rev. 2009.
37. Cole M.P., Chaiswing L., Oberley T.D., Edelmann S.E., Piascik M.T., Lin S.M., Kiningham K.K., St Clair D.K. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity. Cardiovasc. Res. 2006, 69:186-197.
38. Cole M.P., Chaiswing L., Oberley T.D., Edelmann S.E., Piascik M.T., Lin S.-M., Kiningham K.K., St.Clair D.K. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity. Cardiovasc. Res. 2006, 69:186-197.
39. C. Combadière, W. Raoul, X. Guillonneau, F. Sennlaub, Comment on "Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration" by Luhmann et al. (Exp. Eye Res. 2013; 107: 80.doi: 10.1016), Exp. Eye Res. 111 (2013) 134-135.
40. Chang C.-R., Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N.Y. Acad. Sci. 2010, 1201:34-39.
41. Zhu P.-P., Patterson A., Stadler J., Seeburg D.P., Sheng M., Blackstone C. Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J. Biol. Chem. 2004, 279:35967-35974.
42. Din S., Mason M., Völkers M., Johnson B., Cottage C.T., Wang Z., Joyo A.Y., Quijada P., Erhardt P., Magnuson N.S., Konstandin M.H., Sussman M.A. Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc. Nat. Acad. Sci. 2013, 110:5969-5974.
43. Kimata M., Matoba S., Iwai-Kanai E., Nakamura H., Hoshino A., Nakaoka M., Katamura M., Okawa Y., Mita Y., Okigaki M., Ikeda K., Tatsumi T., Matsubara H. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am. J. Physiol.: Heart Circ. Physiol. 2010, 299:H1908-H1916.
44. Rudolph V., Rudolph T.K., Schopfer F.J., Bonacci G., Woodcock S.R., Cole M.P., Baker P.R.S., Ramani R., Freeman B.A. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc. Res. 2010, 85:155-166.
45. Cole M.P., Rudolph T.K., Khoo N.K.H., Motanya U.N., Golin-Bisello F., Wertz J.W., Schopfer F.J., Rudolph V., Woodcock S.R., Bolisetty S., Ali M.S., Zhang J., Chen Y.E., Agarwal A., Freeman B.A., Bauer P.M. Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury. Circ. Res. 2009, 105:965-972.
46. Otterbein L.E., Choi A.M.K. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol.: Lung Cell. Mol. Physiol. 2000, 279:L1029-L1037.
47. Yoshida T., Maulik N., Ho Y.-S., Alam J., Das, Hmox-1 D.K. Constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 2001, 103:1695-1701.
48. Yet S.-F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., Ith B., Melo L.G., Zhang L., Ingwall J.S., Dzau V.J., Lee M.-E., Perrella M.A. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 2001, 89:168-173.
49. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., Griese D.P., Dell'Acqua G., Mann M.J., Oyama J., Yet S.-F., Layne M.D., Perrella M.A., Dzau V.J. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002, 105:602-607.